Net Loss of ANG Lifesciences India reported to Rs 5.93 crore in the quarter ended December 2023 as against net loss of Rs 1.78 crore during the previous quarter ended December 2022. Sales declined 60.47% to Rs 18.55 crore in the quarter ended December 2023 as against Rs 46.93 crore during the previous quarter ended December 2022. ParticularsQuarter Ended�Dec. 2023Dec. 2022% Var. Sales18.5546.93 -60 OPM %-10.305.86 - PBDT-4.45-0.47 -847 PBT-6.37-2.60 -145 NP-5.93-1.78 -233 Powered by Capital Market - Live News

ANG Lifesciences India will hold a meeting of the Board of Directors of the Company on 14 February 2024.Powered by Capital Market - Live News

Net loss of ANG Lifesciences India reported to Rs 2.32 crore in the quarter ended September 2023 as against net profit of Rs 2.63 crore during the previous quarter ended September 2022. Sales declined 44.40% to Rs 33.26 crore in the quarter ended September 2023 as against Rs 59.82 crore during the previous quarter ended September 2022. ParticularsQuarter Ended�Sep. 2023Sep. 2022% Var. Sales33.2659.82 -44 OPM %4.9916.13 - PBDT-0.416.50 PL PBT-2.634.39 PL NP-2.322.63 PL Powered by Capital Market - Live News

ANG Lifesciences India announced that the Annual General Meeting (AGM) of the company will be held on 23 September 2023.Powered by Capital Market - Live News

ANG Lifesciences India announced that the Annual General Meeting (AGM) of the company will be held on 23 September 2023.Powered by Capital Market - Live News